Brianna Osetinsky1,2, Becky L Genberg3, Gerald S Bloomfield4, Joseph Hogan5, Sonak Pastakia6, Edwin Sang7, Anthony Ngressa7, Ann Mwangi7,8, Mark N Lurie9, Stephen T McGarvey9,10, Omar Galárraga1. 1. Department of Health Services Policy & Practice, Brown University, School of Public Health, Providence, RI. 2. Department of Epidemiology and Public Health, Household Economics and Health Systems Research Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 4. Department of Medicine, Duke Global Health Institute, Duke Clinical Research Institute, Duke University, Durham, NC. 5. Department of Biostatistics, School of Public Health, Brown University, Providence, RI. 6. Department of Pharmacy Practice, Purdue University College of Pharmacy, Purdue Kenya Partnership, Eldoret, Kenya. 7. Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya. 8. Department of Behavioral Science, School of Medicine, Moi University, Eldoret, Kenya. 9. Departments of Epidemiology. 10. Anthropology, School of Public Health, International Health Institute, Brown University, Providence, RI.
Abstract
BACKGROUND: As the noncommunicable disease (NCD) burden is rising in regions with high HIV prevalence, patients with comorbid HIV and chronic NCDs may benefit from integrated chronic disease care. There are few evaluations of the effectiveness of such strategies, especially those that directly leverage and extend the existing HIV care system to provide co-located care for NCDs. SETTING: Academic Model of Providing Access to Healthcare, Kenya, provides care to over 160,000 actively enrolled patients in catchment area of 4 million people. METHODS: Using a difference-in-differences design, we analyzed retrospective clinical records of 3603 patients with comorbid HIV and hypertension during 2009-2016 to evaluate the addition of chronic disease management (CDM) to an existing HIV care program. Outcomes were blood pressure (BP), hypertension control, and adherence to HIV care. RESULTS: Compared with the HIV standard of care, the addition of CDM produced statistically significant, although clinically small improvements in hypertension control, decreasing systolic BP by 0.76 mm Hg (P < 0.001), diastolic BP by 1.28 mm Hg (P < 0.001), and increasing the probability of BP <140/90 mm Hg by 1.51 percentage points (P < 0.001). However, sustained control of hypertension for >1 year improved by 7 percentage points (P < 0.001), adherence to HIV care improved by 6.8 percentage points (P < 0.001) and retention in HIV care with no gaps >6 months increased by 10.5 percentage points (P < 0.001). CONCLUSION: A CDM program that co-locates NCD and HIV care shows potential to improve BP and retention in care. Further evaluation of program implementation across settings can inform how to maximize hypertension control among patients with comorbid HIV, and better understand the effect on adherence.
BACKGROUND: As the noncommunicable disease (NCD) burden is rising in regions with high HIV prevalence, patients with comorbid HIV and chronic NCDs may benefit from integrated chronic disease care. There are few evaluations of the effectiveness of such strategies, especially those that directly leverage and extend the existing HIV care system to provide co-located care for NCDs. SETTING: Academic Model of Providing Access to Healthcare, Kenya, provides care to over 160,000 actively enrolled patients in catchment area of 4 million people. METHODS: Using a difference-in-differences design, we analyzed retrospective clinical records of 3603 patients with comorbid HIV and hypertension during 2009-2016 to evaluate the addition of chronic disease management (CDM) to an existing HIV care program. Outcomes were blood pressure (BP), hypertension control, and adherence to HIV care. RESULTS: Compared with the HIV standard of care, the addition of CDM produced statistically significant, although clinically small improvements in hypertension control, decreasing systolic BP by 0.76 mm Hg (P < 0.001), diastolic BP by 1.28 mm Hg (P < 0.001), and increasing the probability of BP <140/90 mm Hg by 1.51 percentage points (P < 0.001). However, sustained control of hypertension for >1 year improved by 7 percentage points (P < 0.001), adherence to HIV care improved by 6.8 percentage points (P < 0.001) and retention in HIV care with no gaps >6 months increased by 10.5 percentage points (P < 0.001). CONCLUSION: A CDM program that co-locates NCD and HIV care shows potential to improve BP and retention in care. Further evaluation of program implementation across settings can inform how to maximize hypertension control among patients with comorbid HIV, and better understand the effect on adherence.
Authors: Benson Njuguna; Susan Vorkoper; Pragna Patel; Mike J A Reid; Rajesh Vedanthan; Colin Pfaff; Paul H Park; Lydia Fischer; Jeremiah Laktabai; Sonak D Pastakia Journal: AIDS Date: 2018-07-01 Impact factor: 4.177
Authors: Abraham M Siika; Joseph K Rotich; Chrispinus J Simiyu; Erica M Kigotho; Faye E Smith; John E Sidle; Kara Wools-Kaloustian; Sylvester N Kimaiyo; Winston M Nyandiko; Terry J Hannan; William M Tierney Journal: Int J Med Inform Date: 2005-06 Impact factor: 4.046
Authors: Cynthia A Binanay; Constantine O Akwanalo; Wilson Aruasa; Felix A Barasa; G Ralph Corey; Susie Crowe; Fabian Esamai; Robert Einterz; Michael C Foster; Adrian Gardner; John Kibosia; Sylvester Kimaiyo; Myra Koech; Belinda Korir; John E Lawrence; Stephanie Lukas; Imran Manji; Peris Maritim; Francis Ogaro; Peter Park; Sonak D Pastakia; Wilson Sugut; Rajesh Vedanthan; Reuben Yanoh; Eric J Velazquez; Gerald S Bloomfield Journal: J Am Coll Cardiol Date: 2015-12-08 Impact factor: 24.094
Authors: Shukri F Mohamed; Martin K Mutua; Richard Wamai; Frederick Wekesah; Tilahun Haregu; Pamela Juma; Loise Nyanjau; Catherine Kyobutungi; Elijah Ogola Journal: BMC Public Health Date: 2018-11-07 Impact factor: 3.295
Authors: Becky L Genberg; Juddy Wachira; Jon A Steingrimsson; Sonak Pastakia; Dan N Tina Tran; Jamil AbdulKadir Said; Paula Braitstein; Joseph W Hogan; Rajesh Vedanthan; Suzanne Goodrich; Catherine Kafu; Marta Wilson-Barthes; Omar Galárraga Journal: BMJ Open Date: 2021-05-18 Impact factor: 3.006
Authors: Alexander Kintu; David Sando; Samson Okello; Gerald Mutungi; David Guwatudde; Nicolas A Menzies; Goodarz Danaei; Stéphane Verguet Journal: J Int AIDS Soc Date: 2020-06 Impact factor: 5.396
Authors: Risa M Hoffman; Florence Chibwana; Daniel Kahn; Ben Allan Banda; Linna Phiri; Mayamiko Chimombo; Chiulemu Kussen; Hitler Sigauke; Agnes Moses; Joep J van Oosterhout; Sam Phiri; Jesse W Currier; Judith S Currier; Corrina Moucheraud Journal: Glob Heart Date: 2021-12-06
Authors: Jiancheng Ye; Ikechukwu A Orji; Abigail S Baldridge; Tunde M Ojo; Grace Shedul; Eugenia N Ugwuneji; Nonye B Egenti; Kasarachi Aluka-Omitiran; Rosemary C B Okoli; Helen Eze; Ada Nwankwo; Lisa R Hirschhorn; Aashima Chopra; Boni M Ale; Gabriel L Shedul; Priya Tripathi; Namratha R Kandula; Mark D Huffman; Dike B Ojji Journal: JAMA Netw Open Date: 2022-09-01
Authors: Becky L Genberg; Marta G Wilson-Barthes; Victor Omodi; Joseph W Hogan; Jon Steingrimsson; Juddy Wachira; Sonak Pastakia; Dan N Tran; Zana W Kiragu; Laura J Ruhl; Molly Rosenberg; Sylvester Kimaiyo; Omar Galárraga Journal: AIDS Date: 2021-10-01 Impact factor: 4.632